PRO MEDICUS LIMITED (PME)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

PME - PRO MEDICUS LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.02
Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH
Pro Medicus is an imaging IT company providing a range of radiology software and services, medical accounting and clinical reporting to the health care sector. Founded in 1983, the company listed on the ASX in 2000.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$82.68
03 Oct |
OPEN $83.22 |
HIGH $84.00 |
250,752 LOW $82.07 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
4DX . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . MEB . MX1 . NAN . ONE . PCK . PEB . PGC . RMD . SOM . TRJ . UBI . VHT . VTI . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 58.1 | 76.1 | xxx |
DPS (cps) | xxx | 30.0 | 38.6 | xxx |
EPS Growth | xxx | 36.4% | 30.9% | xxx |
DPS Growth | xxx | 36.4% | 28.7% | xxx |
PE Ratio | xxx | N/A | 108.3 | xxx |
Dividend Yield | xxx | N/A | 0.5% | xxx |
Div Pay Ratio(%) | xxx | 51.6% | 50.8% | xxx |
Last ex-div: 06/09 - ex-div 17c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 58.1 |
DPS All | xxx | xxx | xxx | xxx | xxx | 30.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 124.9 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 132.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 64.8 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 48.56 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 50.43 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 49.84 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 33.77 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 50.43 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 68.57 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 38.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 1 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 2 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 121 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 49.40 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross

Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 6.4 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 5.16 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 33 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 8 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
PME STOCK CHART

FNArena News on PME
1 |
Rudi’s View: To Sell Or Not To Sell?10:00 AM - Rudi's View |
2 |
Australian Broker Call *Extra* Edition – Sep 27, 2023Sep 27 2023 - Daily Market Reports |
3 |
Rudi’s Views: August 2023 – Winners & LosersSep 13 2023 - Rudi's View |
4 |
Rudi’s View: Outlook Negative, With Plenty Of Silver LiningsSep 06 2023 - Rudi's View |
5 |
Rudi’s View: Resilience Shines, Forecasts SlideAug 23 2023 - Rudi's View |
Latest Medical Equipment & Devices News
1 |
Dr Boreham’s Crucible: PainchekSep 11 2023 - Small Caps |
2 |
Margins Signal Integral Diagnostics RecoverySep 07 2023 - Australia |
3 |
ResMed: Finding A Base?Aug 15 2023 - Technicals |
4 |
August Turns ResMed Into Nigel NoMatesAug 09 2023 - Australia |
5 |
Dr Boreham’s Crucible: Lumos DiagnosticsJun 19 2023 - Small Caps |
6 |
Fisher & Paykel Healthcare: Lower Margin, Higher SpendingMay 30 2023 - Australia |
7 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
8 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |
9 |
Dr Boreham’s Crucible: Volpara Health TechnologiesApr 26 2023 - Small Caps |
10 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |